Becton Dickinson and CoNYSE:BDX
- LAST PRICE240.9700
- TODAY'S CHANGE (%)9.0000 (3.8798%)
- Bid / Lots240.7800/ 4
- Ask / Lots240.9900/ 1
- Open / Previous Close235.0000 / 231.9700
- Day Range
- 52 Week Range
- Volume474,918
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BDX |
|---|---|---|
| 09:32 ET | 35258 | 236.0325 |
| 09:34 ET | 19409 | 235.03 |
| 09:36 ET | 4309 | 236.335 |
| 09:38 ET | 11600 | 237.225 |
| 09:39 ET | 4143 | 237.25 |
| 09:41 ET | 4777 | 236.84 |
| 09:43 ET | 15067 | 237.62 |
| 09:45 ET | 19777 | 238.64 |
| 09:48 ET | 16440 | 238.89 |
| 09:50 ET | 6926 | 239.42 |
| 09:52 ET | 13706 | 239.2 |
| 09:54 ET | 3815 | 238.43 |
| 09:56 ET | 10230 | 238.51 |
| 09:57 ET | 5405 | 238.19 |
| 09:59 ET | 2820 | 239.045 |
| 10:01 ET | 11149 | 239.445 |
| 10:03 ET | 13613 | 239.61 |
| 10:06 ET | 20176 | 241 |
| 10:08 ET | 25381 | 241.03 |
| 10:10 ET | 8765 | 241.63 |
| 10:12 ET | 4208 | 241.27 |
| 10:14 ET | 5171 | 240.74 |
| 10:15 ET | 5761 | 240.9 |
| 10:17 ET | 7591 | 240.595 |
| 10:19 ET | 7454 | 240.71 |
| 10:21 ET | 800 | 240.875 |
| 10:24 ET | 4816 | 240.85 |
| 10:26 ET | 1763 | 240.97 |
Today
DJ Becton Dickinson to Acquire Edwards Lifesciences' Unit for $4.2 Billion in Cash -- WSJ, from 2 hours ago by Dow Jones
2 hours ago by Dow JonesDJ Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2B in Cash, from 4 hours ago by Dow Jones
4 hours ago by Dow JonesDJ Edwards Lifesciences To Sell Its Critical Care Product Group For $4.2 Billion To Becton Dickinson -- MarketWatch, from 4 hours ago by Dow Jones
4 hours ago by Dow JonesBD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader, from 4 hours ago by Dow Jones
4 hours ago by Dow Jones*DJ BD To Acquire Edwards Lifesciences' Critical Care Product Group For $4.2 Billion To Expand Smart Connected Care Solutions And Become An Advanced Monitoring Technology Leader >BDX EW, from 4 hours ago by Dow Jones
4 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Becton Dickinson and Co | 67.0B | 51.3x | +11.04% |
Dexcom Inc | 47.2B | 76.3x | --- |
IDEXX Laboratories Inc | 41.0B | 47.5x | +18.62% |
Mettler-Toledo International Inc | 30.0B | 39.1x | +12.39% |
Medtronic PLC | 106.7B | 29.8x | -4.17% |
Baxter International Inc | 17.4B | -449.0x | --- |
Company Information
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. The Company's BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, and pharmaceutical systems. The Company's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
Contact Information
- Headquarters
- One Becton DriveFRANKLIN LAKES, NJ, United States 07417-1880
- Phone
- 201-847-6800
- Fax
- ---
Executives
- Chairman of the Board, President, Chief Executive Officer
- Thomas Polen
- Chief Financial Officer, Executive Vice President
- Christopher DelOrefice
- Executive Vice President, President - Life Sciences Segment
- David Hickey
- Chief People Officer, Executive Vice President
- Shana Neal
- Executive Vice President, President, North America, Chief Marketing Officer
- Antoine Ezell
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $67.0B |
|---|---|
Revenue (TTM) | $19.7B |
Shares Outstanding | 289.0M |
Dividend Yield | 1.58% |
Annual Dividend Rate | 3.8000 USD |
Ex-Dividend Date | 06-10-24 |
Pay Date | 06-28-24 |
Beta | 0.45 |
EPS | $4.70 |
Book Value | $88.83 |
P/E Ratio | 51.3x |
Price/Sales (TTM) | 3.4 |
Price/Cash Flow (TTM) | 18.3x |
Operating Margin | 10.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
